CONMED CNMD Amortization
Amortization at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:OtherAmortizationOfDeferredCharges.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CONMED's amortization?
- CONMED (CNMD) reported amortization of $14.66M in Q1 2026.
- How has CONMED's amortization changed year-over-year?
- CONMED's amortization increased by 4.6% year-over-year, from $14.02M to $14.66M.
- What is the long-term trend for CONMED's amortization?
- Over 4 years (2021 to 2025), CONMED's amortization has grown at a 1.3% compound annual growth rate (CAGR), from $54.25M to $57.14M.
- What does amortization mean?
- This metric represents the non-cash expense recognized over time for the systematic allocation of deferred costs, such as debt issuance expenses or other capitalized charges. It reflects the gradual consumption of these assets, impacting net income without affecting immediate cash flow. Investors monitor this to distinguish between actual cash outflows and accounting-driven expense recognition.